{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:02:26Z","timestamp":1792544546361,"version":"4.5.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Hidradenitis suppurativa (HS) fistulas are likely to persist without surgical intervention. Hypertonic saline (HTS), a venous sclerosant, disrupts the endothelial lining leading to occlusion and fibrosis when used for venous insufficiency.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>To evaluate the efficacy and tolerability of HTS sclerotherapy for HS fistulas.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS AND MATERIALS<\/jats:title>\n            <jats:p>This Institutional review board\u2013approved, nonrandomized, clinical trial included adult patients with a diagnosis of HS and at least one confirmed HS fistula who underwent HTS injections into their fistulas every two weeks followed by a 4-week follow-up period. The study was performed from 2016 to 2019 at two academic outpatient dermatology clinics in Boston, MA. Primary outcomes were physician-assessed improvement of HS fistula characteristics between final and baseline visits and physician-assessed HS improvement during course of study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>Overall, 21 patients participated. Physician-assessed overall HS improvement was significant between Visits 2 and 3 (<jats:italic toggle=\"yes\">p<\/jats:italic> = .036). Drainage (<jats:italic toggle=\"yes\">p<\/jats:italic> = .035), erythema (<jats:italic toggle=\"yes\">p<\/jats:italic> = .008), and swelling (<jats:italic toggle=\"yes\">p<\/jats:italic> = .025) demonstrated statistically significant improvement from baseline to final visit. Dermatology life quality index scores significantly improved from baseline to Visit 2 (<jats:italic toggle=\"yes\">p<\/jats:italic> = .0005), Visit 3 (<jats:italic toggle=\"yes\">p<\/jats:italic> = .0008), and final visit (<jats:italic toggle=\"yes\">p<\/jats:italic> = .011). Numeric rating scale stinging scores increased with sclerosant volume.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>This study demonstrated physician-reported and patient-reported improvement in fistulas following serial HTS injections. HTS injections were well tolerated.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000003510","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T14:03:20Z","timestamp":1662127400000},"page":"954-960","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["An Open-Label, Prospective, Pilot Study of Hypertonic Saline for Hidradenitis Suppurativa"],"prefix":"10.1097","volume":"48","author":[{"given":"Martina L.","family":"Porter","sequence":"first","affiliation":[{"name":"Clinical Laboratory for Epidemiology and Applied Research in Skin, Harvard Medical School, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prerna","family":"Salian","sequence":"additional","affiliation":[{"name":"Clinical Laboratory for Epidemiology and Applied Research in Skin, Harvard Medical School, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Rosales Santillan","sequence":"additional","affiliation":[{"name":"Clinical Laboratory for Epidemiology and Applied Research in Skin, Harvard Medical School, Boston, Massachusetts;"},{"name":"Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Greif","sequence":"additional","affiliation":[{"name":"Clinical Laboratory for Epidemiology and Applied Research in Skin, Harvard Medical School, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa B.","family":"Kimball","sequence":"additional","affiliation":[{"name":"Clinical Laboratory for Epidemiology and Applied Research in Skin, Harvard Medical School, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,8,9]]},"reference":[{"key":"R1-20250731","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/bjd.15748","article-title":"Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity","volume":"177","author":"Zouboulis","year":"2017","journal-title":"Br J Dermatol"},{"key":"R2-20250731","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11154-016-9328-5","article-title":"Evidence-based approach to the treatment of hidradenitis suppurativa\/acne inversa, based on the European guideline for hidradenitis suppurativa","volume":"17","author":"Gulliver","year":"2016","journal-title":"Rev Endocr Metab Disord"},{"key":"R3-20250731","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/jama.2017.16691","article-title":"Hidradenitis suppurativa: advances in diagnosis and treatment","volume":"318","author":"Saunte","year":"2017","journal-title":"JAMA"},{"key":"R4-20250731","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/exd.13978","article-title":"Contribution of fibroblasts to tunnel formation and inflammation in hidradenitis suppurativa\/acne inversa","volume":"28","author":"Frew","year":"2019","journal-title":"Exp Dermatol"},{"key":"R5-20250731","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jaad.2016.05.009","article-title":"Color Doppler ultrasound assessment of morphology and types of fistulous tracts in hidradenitis suppurativa (HS)","volume":"75","author":"Wortsman","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"R6-20250731","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/DSS.0000000000000824","article-title":"Carbon dioxide laser treatment using methylene blue\u2013assisted sinus tract identification in hidradenitis suppurativa","volume":"42","author":"Grimstad \u00d8","year":"2016","journal-title":"Dermatol Surg"},{"key":"R7-20250731","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1097\/DSS.0000000000001916","article-title":"Defining fistular patterns in hidradenitis suppurativa: impact on the management","volume":"45","author":"Martorell","year":"2019","journal-title":"Dermatol Surg"},{"key":"R8-20250731","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jaad.2017.02.026","article-title":"New and traditional surgical approaches to hidradenitis suppurativa: a case series of 9 patients","volume":"76","author":"Danby","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"R9-20250731","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1365-2133.1999.02970.x","article-title":"Forms of epithelial differentiation of draining sinus in acne inversa (hidradenitis suppurativa)","volume":"141","author":"Kurzen","year":"1999","journal-title":"Br J Dermatol"},{"key":"R10-20250731","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jamadermatol.2014.430","article-title":"Cryoinsufflation for Hurley Stage II Hidradenitis Suppurativa: a useful treatment option when systemic therapies should be avoided","volume":"150","author":"Pagliarello","year":"2014","journal-title":"JAMA Dermatol"},{"key":"R11-20250731","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jdcr.2020.10.004","article-title":"Tumescent triamcinolone infiltration: a new approach for the management of recalcitrant hidradenitis suppurativa","volume":"6","author":"Dautriche","year":"2020","journal-title":"JAAD Case Rep"},{"key":"R12-20250731","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/DSS.0000000000000225","article-title":"Consensus for sclerotherapy","volume":"40","author":"Weiss","year":"2014","journal-title":"Dermatol Surg"},{"key":"R13-20250731","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1055\/s-2005-921954","article-title":"Injection sclerotherapy","volume":"22","author":"Worthington-Kirsch","year":"2005","journal-title":"Semin Intervent Radiol"},{"key":"R14-20250731","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/1531003507305884","article-title":"Sclerotherapy: introductions to solutions and techniques","volume":"19","author":"Dietzek","year":"2007","journal-title":"Perspect Vasc Surg Endovasc Ther"},{"key":"R15-20250731","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4103\/0378-6323.77478","article-title":"Standard guidelines for care: sclerotherapy in dermatology","volume":"77","author":"Khunger","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R16-20250731","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1468-3083.2012.04468.x","article-title":"Depression in patients with hidradenitis suppurativa","volume":"27","author":"Onderdijk","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R17-20250731","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1046\/j.1365-2133.2001.04137.x","article-title":"Morbidity in patients with hidradenitis suppurativa","volume":"144","author":"von der Werth","year":"2001","journal-title":"Br J Dermatol"},{"key":"R18-20250731","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/j.1524-4725.2012.02422.x","article-title":"Treatment of reticular and telangiectatic leg veins: double-blind, prospective comparative trial of polidocanol and hypertonic saline","volume":"38","author":"Peterson","year":"2012","journal-title":"Dermatol Surg"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000003510","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T22:07:32Z","timestamp":1753999652000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000003510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,9]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000003510","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,9]]}}}